Market access for digital therapies and digital medicines

Pharma Market Access Insights - from Mtech Access

In this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcomes.
In the webinar, Clare asks Shefali about:

• The opportunities for digital technologies in neurology and how they may impact existing care pathways in the future
• How the digital technology market differs from the pharmaceutical market
• Regulatory and reimbursement challenges for digital technologies
• Her experiences in launching digital technologies in markets such as the US and Germany
• How digital technologies can be used to enhance and complement existing treatments/pathways of care
• Lessons other digital health, medical device and pharmaceutical companies can learn from Shefali’s experiences

The episode was first broadcast as a live webinar in June 2023. Learn more about this webinar at https://mtechaccess.co.uk/market-access-for-digital-therapies/
Learn how Mtech Access can support you with your market access journey at: https://mtechaccess.co.uk/global-market-access-and-pricing/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Bab

1. Introductions and welcome (00:00:00)

2. Opportunities for digital technologies in neurology (00:06:58)

3. Developing a new digital therapeutic - the process and key challenges (00:11:04)

4. Getting your technology to patients in different countries (00:14:16)

5. Post regulatory approval - Reimbursement challenges (00:19:13)

6. Reimbursement and market access strategies (00:26:23)

7. Patients' perceptions of digital therapeutics (00:28:53)

8. Healthcare professionals' perceptions of digital therapeutics (00:32:01)

9. The future of digital therapeutics (00:33:40)

10. Lessons for Pharma and Medtech companies (00:35:58)

11. What needs to change for market access for digital therapeutics? (00:39:31)